Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors
Introduction In consonance with current the World Health Organization (WHO) classification of the central nervous system (CNS) tumors (2016), histological diagnosis of gliomas should be reinforced by molecular information. This study was performed to determine the frequency of isocitrate...
Saved in:
| Main Authors: | Santosh Sharma, Kusum Mathur, Alka Mittal, Meel Mukta, Arpita Jindal, Mukesh Kumar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2023-08-01
|
| Series: | Indian Journal of Neurosurgery |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1743265 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vorasidenib for IDH-mutant grade 2 gliomas: clinical advances and future directions
by: Zhenjiang Pan, et al.
Published: (2025-06-01) -
Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective study
by: Nicolas Goliot, et al.
Published: (2025-08-01) -
Molecular Biomarkers of Glioma
by: Punsasi Rajakaruna, et al.
Published: (2025-05-01) -
Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma
by: Alexander S. Himstead, et al.
Published: (2025-01-01) -
Diffuse gliomas: insights into clinical and histopathological features and survival rates from two centers in a middle-income country
by: Edgar G. Ordóñez-Rubiano, et al.
Published: (2025-07-01)